CG Oncology, Inc. (CGON)
NASDAQ: CGON · Real-Time Price · USD
28.67
+0.65 (2.32%)
Dec 20, 2024, 4:00 PM EST - Market closed
CG Oncology Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -72.8 | -48.61 | -35.44 | -12.84 |
| Depreciation & Amortization | 0.04 | 0.02 | 0.02 | 0.01 |
| Other Amortization | -0.01 | 0 | 0.01 | 0.01 |
| Loss (Gain) From Sale of Investments | -7.71 | -2.88 | - | - |
| Stock-Based Compensation | 7.19 | 1.53 | 0.68 | 1.11 |
| Other Operating Activities | 0 | 0.82 | 0.5 | 0.02 |
| Change in Accounts Payable | 2.22 | 2.01 | -0.02 | 0.58 |
| Change in Other Net Operating Assets | -1.58 | 1.43 | 4.46 | -2.55 |
| Operating Cash Flow | -72.7 | -45.68 | -29.8 | -13.65 |
| Capital Expenditures | -0.03 | - | -0.01 | -0.1 |
| Investment in Securities | -296.11 | -121.2 | -55.34 | - |
| Investing Cash Flow | -296.14 | -121.2 | -55.35 | -0.1 |
| Long-Term Debt Issued | - | - | - | 15.2 |
| Long-Term Debt Repaid | - | -16.29 | - | - |
| Net Debt Issued (Repaid) | -0.37 | -16.29 | - | 15.2 |
| Issuance of Common Stock | 408.92 | 2.08 | 0.17 | 0.25 |
| Other Financing Activities | -6.58 | -3.42 | -0.47 | - |
| Financing Cash Flow | 401.97 | 87 | 119.69 | 15.45 |
| Net Cash Flow | 33.14 | -79.88 | 34.54 | 1.7 |
| Free Cash Flow | -72.72 | -45.68 | -29.82 | -13.75 |
| Free Cash Flow Margin | -10631.73% | -22391.67% | -15611.52% | -132.76% |
| Free Cash Flow Per Share | -1.56 | -10.55 | -7.97 | -3.77 |
| Cash Interest Paid | - | 0.38 | 1.09 | 0.31 |
| Levered Free Cash Flow | -54.28 | -28.07 | -16.95 | - |
| Unlevered Free Cash Flow | -54.28 | -28.07 | -16.96 | - |
| Change in Net Working Capital | 1.49 | -5.04 | -4.39 | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.